Jeff Wren

Vice President of Biotherapies
AABB
Minneapolis, Minnesota, United States

Presentation(s):

• AM24-MN-41-L - The AABB Cellular Starting Material Forum: From Consent to Characterization - Enhancing Allogeneic Donor Practices

  Monday, October 21, 2024
  9:30 AM - 11:00 AM  

  Disclosure(s): No financial relationships to disclose